GlassScriptPhysician profile
Albert K Chan
NPI 1669598629
$14,577.10
in general payments reported to CMS, 2019-2025
43 companies · $2,470 in 2025
The $2,470 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,441 · 2020: $650 · 2021: $747 · 2022: $1,281 · 2023: $3,730 · 2024: $3,257 · 2025: $2,470.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,053 · Travel and Lodging: $1,185 · Consulting Fee: $219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,053.47 |
| Travel and Lodging | $1,184.71 |
| Consulting Fee | $219.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,527.51 | 2019-2025 | Avvigo Guidance System, General - Balloon Catheters, Opticross |
| Abiomed | $1,373.15 | 2022-2025 | Impella |
| Medtronic, INC. | $1,242.28 | 2021-2025 | Onyx Frontier, Symplicity G3, Na |
| Janssen Research & Development, LLC | $1,037.71 | 2023 | |
| Amgen INC. | $1,019.41 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $809.87 | 2020-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $658.08 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $582.65 | 2019-2024 | Brilinta, Farxiga, Wainua |
| Medtronic Vascular, INC. | $504.11 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $452.23 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $368.14 | 2019-2025 | Camzyos, Eliquis |
| Abbott Laboratories | $364.97 | 2019-2025 | Aveir, Mitraclip, Supera |
| Shockwave Medical, INC | $364.46 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Asahi Intecc USA, INC. | $352.69 | 2019-2023 | Asahi Ptca Guide Wire |
| Philips North America LLC | $352.42 | 2022-2025 | (9266) Elca, Azurion 7 M20 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $259.69 | 2019-2024 | Recross |
| Jenavalve Technology, INC. | $219.49 | 2024 | |
| Chiesi USA, INC. | $204.51 | 2021-2025 | Kengreal, Cleviprex |
| Livanova USA, INC. | $185.76 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $180.29 | 2022-2024 | Verquvo |
| Impulse Dynamics (USA) INC. | $162.04 | 2023 | Optimizer |
| Lexicon Pharmaceuticals, INC. | $146.90 | 2023-2024 | Inpefa |
| Novo Nordisk INC | $141.40 | 2023-2024 | Ozempic, Rybelsus |
| Edwards Lifesciences Corporation | $122.40 | 2021-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Pascal |
| Zoll Circulation INC | $120.87 | 2022-2025 | Catheter, Downstream Cartridge, Therox Ds2 Console |
| Pfizer INC. | $87.90 | 2020-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $85.61 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $80.37 | 2023 | Jardiance |
| Lantheus Medical Imaging, INC. | $73.98 | 2019-2025 | Definity |
| La Jolla Pharmaceutical Company | $72.20 | 2024-2025 | Giapreza |
| Cvrx, INC. | $59.44 | 2024 | Barostim Neo System |
| Alnylam Pharmaceuticals INC. | $53.43 | 2025 | Amvuttra |
| Janssen Scientific Affairs, LLC | $45.03 | 2022 | |
| Siemens Medical Solutions USA, INC. | $43.95 | 2022-2023 | |
| Daiichi Sankyo INC. | $40.46 | 2023 | Injectafer |
| Cordis US Corp. | $38.15 | 2025 | Mynx Control Venous |
| Ge Healthcare | $29.88 | 2019-2022 | |
| Angiodynamics, INC. | $28.07 | 2020 | |
| Becton, Dickinson and Company | $23.50 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.62 | 2025 | Gattex |
| Teleflex LLC | $16.03 | 2022 | |
| Davol INC. | $13.99 | 2024 | Tridyne Vascular Sealant |
| Cardiovascular Systems INC. | $13.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.